Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹1,596.60
49.80 (3.22%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹483 Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
26.3
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹1,067+49.6%
52W High₹1,774-10.0%
Current Price
₹1,596.60
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹1,277.28
Upper Circuit₹1,915.92
Reference Price
₹1,596.60
Investment Checklist
Triple Bottom on 1D (BREAKOUT CONFIRMED) — target ₹1678.2
Inverse Head and Shoulders on 1D (BREAKOUT CONFIRMED) — target ₹1652.0
Trend: Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
Composite score 57.82 (STRONG_BUY) with 87.0% confidence
EMA(9) Crossover: Price crossed above EMA(9): Fresh bullish momentum signal.
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
87%
Trend
BULLISH
BULLISH
Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
EMA20
1521.26
EMA50
1479.34
EMA200
1348.63
Price Action
MIXED
NEUTRAL
Higher Highs3
Higher Lows7
Lower Highs6
Lower Lows2
Support & Resistance Levels
Resistance (Above)
₹1740.00
₹1766.95
Support (Below)
₹1539.00
₹1503.55
₹1440.50
₹1420.00
₹1380.30
Volume Analysis
TrendINCREASING
Change+310.70%
Unusual VolumeNo
Stop Loss Levels
Fixed Risk
1% Risk₹1580.63
3% Risk₹1548.70
5% Risk₹1516.77
7% Risk (Custom)
₹1484.84Technical Levels
1x ATR (Volatility)₹1503.09
2x ATR (Swing)₹1409.58
3x ATR (Trend)₹1316.07
Immediate Support₹1539.00
Moving Averages
EMA 9 (Short-term)₹1561.42
EMA 20 (Medium-term)₹1521.26
EMA 50 (Trend)₹1479.34
EMA 200 (Long-term)₹1348.63
Financials
Financial Analysis
| Metric | Dec '24 | Mar '25 | Jun '25 | Sep '25 |
|---|---|---|---|---|
| Revenue | ₹84.6 Cr | ₹81.2 Cr | ₹82.5 Cr | ₹81.4 Cr |
| Net Profit | ₹5.5 Cr | ₹3 Cr | ₹4.2 Cr | ₹6.1 Cr |
| EPS | ₹18.08 | — | ₹13.75 | ₹20.19 |
| Operating Profit | ₹12.8 Cr | ₹9.5 Cr | ₹12.7 Cr | ₹14 Cr |
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| HALEOS LABS LIMITED | ₹1,596.60 | +3.22% | 26.3 | ₹483 Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 24 Sept 2025 | Dividend - Rs 1.50 Per Share | DIVIDEND |
| 23 Sept 2024 | Annual General Meeting/Dividend - Rs 1.50 Per Share | AGM |
| 22 Sept 2023 | Annual General Meeting/Dividend - Rs 1.50 Per Share | AGM |
| 22 Sept 2022 | Annual General Meeting/Dividend - Rs 1.50 Per Share | AGM |
| 20 Sept 2021 | Annual General Meeting/Dividend - Rs 1.50 Per Share | AGM |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for HALEOSLABS
View AllNEWS
negative
Business Standard - Markets 18d ago
Hybrid Financial Services Ltd leads losers in 'B' group
Mahalaxmi Rubtech Ltd, Haleos Labs Limited, ABM Knowledgeware Ltd and Banswara Syntex Ltd are among the other losers in the BSE's 'B' group today, 22 June 2026.
ABMINTLLTDABMKNOBANSWRASBSEHALEOSLABSHYBRIDFINJMFINANCILMHLXMIRUFinancial ServicesHealthcare
NEWS
negative
Business Standard - Markets 36d ago
Thacker & Company Ltd leads losers in 'B' group
Mahalaxmi Rubtech Ltd, Haleos Labs Limited, Shah Metacorp Ltd and Umiya Buildcon Ltd are among the other losers in the BSE's 'B' group today, 04 June 2026.
BSEHALEOSLABSMHLXMIRUSHAHTHACKERUMIYA-MROCapital GoodsFinancial Services
NEWS
negative
Business Standard - Markets 38d ago
Worth Peripherals Ltd leads losers in 'B' group
Mahalaxmi Fabric Mills Ltd, Rajdarshan Industries Ltd, Archidply Decor Ltd and Haleos Labs Limited are among the other losers in the BSE's 'B' group today, 02 June 2026.
ADLARCHIDPLYARENTERPBSEHALEOSLABSMFMLWORTHPERICapital GoodsConsumer Durables